Breast cancer prevention study
Women in the Northern Rivers area with a family history of breast cancer are needed to join an international pioneering study that could help prevent the disease.
Lismore Base Hospital is one of more than 30 hospitals across Australia and New Zealand taking part in the International Breast Cancer Intervention Study (IBIS-II). The study will involve 10,000 women across the globe and eligible women in the Northern Rivers are encouraged to join. The research aims to find out whether a drug widely used to treat breast cancer, anastrozole, can also be used to prevent breast cancer. Previous research using anastrozole as a treatment for early breast cancer suggests that it could prevent up to 70% of new tumours occurring in women at increased risk, or 300,000 breast cancers per year, worldwide.
“It’s important that Northern Rivers women have access to the study and have the opportunity to contribute to vital breast cancer prevention research,” Lismore-based oncologist Dr Adam Boyce said. “The findings from this research may provide a new approach to prevent breast cancer, not only for women today, but also for their daughters and granddaughters in the future.”
To join the study, women must be post-menopausal, aged between 40 and 70, and have a family history of breast cancer. Women joining the study will take a tablet a day for five years and receive a bone-health check and regular mammograms. They have clinical check-ups twice a year in the first year and once a year in the following four years.
For more information about the IBIS-II study call 1800 640 709 or register your interest online at www.anzbctg.org.